We are a specialty pharmaceutical company that combines formulation experience and knowledge with our proprietary and patented Controlled Delivery Technology (CDT® ) platforms to develop and commercialize novel prescription, over-the-counter (OTC), and nutritional products. Our CDT platforms are based on multiple issued and pending patents and other intellectual property for custom designed extended release and/or enhanced performance of active pharmaceutical ingredients and nutritional products. Our innovative drug delivery technologies enable us to customize the formulations of tablets or capsules in order to release their active ingredients predictably over a specified timeframe of up to 24 hours. Our platforms are designed to offer a cost effective means to reduce the frequency of drug administration, improve the effectiveness of the drug treatment, ensure greater patient compliance with a treatment program, reduce side effects, and/or increase drug safety.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Nutraceutix Inc, Scolr Inc
SEC CIK
Corporate docs
IRS number
911689591
Latest filings (excl ownership)
REVOKED
Registration or securities revoked
16 Jul 14
8-K
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
4 Mar 13
8-K
Entry into a Material Definitive Agreement
24 Oct 12
8-K
SCOLR Pharma Announces Unaudited Net Sales of Nutritional Products
28 Jun 12
8-K
Entry into a Material Definitive Agreement
15 Jun 12
D
$1.35M in debt / options, sold $308K, 7 investors
18 May 12
8-K
Entry into a Material Definitive Agreement
10 May 12
8-K
Departure of Directors or Certain Officers
5 Apr 12
NT 10-K
Notice of late annual filing
30 Mar 12
8-K
Entry into a Material Definitive Agreement
26 Mar 12
Latest ownership filings
No filings